n-Butyl-β-D-fructofuranoside |
| Catalog No.GC66343 |
n-부틸-β-D-프룩토푸라노사이드는 칸가이산에서 분리될 수 있습니다. 821d96072c2d58d8970e76f526b0f6b8n-부틸-β-D-프룩토푸라노사이드는 미토콘드리아 경로를 통해 세포사멸을 유도합니다. 821d96072c2d58d8970e76f526b0f6b8n-부틸-β-D-프룩토푸라노사이드는 암 연구에 사용할 수 있습니다.821d96072c2d58d8970e76f526b0f6b8
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 80971-60-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
n-Butyl-β-D-fructofuranoside could be isolated from kangaisan. n-Butyl-β-D-fructofuranoside induces apoptosis through the mitochondrial pathway. n-Butyl-β-D-fructofuranoside can be used for cancer research[1].
n-Butyl-β-D-fructofuranoside (0-23.6 μg/mL; 24-78 hours) has antiproliferation activity and inhibits the viability of Bel-7402 cells[1].
n-Butyl-β-D-fructofuranoside (0-75 μg/mL; 0-72 hours) inhibits BEL-7402 cells by interfering with cell cycle and inducing apoptosis[1].
Cell Viability Assay[1]
| Cell Line: | Bel-7402 cells |
| Concentration: | 0.47, 2.95, 5.90, 11.8, 17.7 and 23.6 μg/mL |
| Incubation Time: | 24, 48 and 72 hours |
| Result: | Inhibited the proliferation of Bel-7402 cells at both time- and dose-dependent manner. |
Cell Cycle Analysis[1]
| Cell Line: | Bel-7402 cells |
| Concentration: | 0, 50 and 75 μg/mL |
| Incubation Time: | 24, 48 and 72 hours |
| Result: | Induced cell cycle arrest at G0/G1 phase. |
Western Blot Analysis[1]
| Cell Line: | Bel-7402 cells |
| Concentration: | 23.6 μg/mL |
| Incubation Time: | 0, 24, 48 and 72 hours |
| Result: | Decreased Bcl-2 and increased Bax and p53 levels in a time manner. |
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *